Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 10:01 PM ET

Date/Time Source News Release
12/31/2024 08:00 AM EST ACCESSWIRE EQ Inc. Announces Appointment of Interim CFO
11/25/2024 08:00 AM EST ACCESSWIRE EQ Inc. Reports Third Quarter Financial Results
11/13/2024 04:01 PM EST Business Wire Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
11/13/2024 08:00 AM EST Business Wire Equillium to Present at the Stifel Healthcare Conference
11/12/2024 08:00 AM EST Business Wire Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer
10/31/2024 07:00 AM EDT Business Wire Equillium Maintains Rights to Itolizumab Following Ono Partnership
10/29/2024 08:00 AM EDT ACCESSWIRE EQ Works and TorStar Partner to Supercharge Rewards Program
10/07/2024 08:00 AM EDT Business Wire Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
09/10/2024 08:00 AM EDT Business Wire Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
09/04/2024 08:00 AM EDT Business Wire Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Page

Additional News

As of January 3, 2025 • 10:01 PM ET

Date/Time Source News Release
11/16/2024 04:39 AM EST US Earnings Reports Expected earnings - Equillium Inc.
11/12/2024 09:35 AM EST Zacks Opus Genetics, Inc. (IRD) Reports Q3 Loss, Tops Revenue Estimates
11/06/2024 10:00 AM EST Zacks Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth
10/31/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Thu, Oct 31, 2024 as of 4:00 pm ET
10/31/2024 11:47 AM EDT SeekingAlpha Equillium says Ono not acquiring itolizumab, stock craters 36%
10/31/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Oct 31, 2024 as of 10.00 am ET
10/31/2024 08:25 AM EDT Zacks Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates
08/31/2024 05:39 AM EDT US Earnings Reports Expected earnings - Equillium Inc.
08/09/2024 03:24 AM EDT SeekingAlpha Equillium GAAP EPS of $0.01 beats by $0.16, revenue of $13.9M beats by $7.57M
08/08/2024 05:35 PM EDT Zacks Equillium, Inc. (EQ) Beats Q2 Earnings and Revenue Estimates
Page